today announced that the Singapore Health Sciences Authority (HSA) has officially accepted the New Drug Application (NDA) for Equecabtagene Autoleucel. This treatment is indicated for patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback